Primary Objectives:~1. To determine the safety and feasibility of anti- MESO CAR-T cells therapy for Refractory-Relapsed Ovarian Cancer~Secondary Objectives:~To access the efficacy of anti- MESO CAR-T cells in patients with ovarian cancer.~To determine in vivo dynamics and persistency of anti- MESO CAR-T cells~To assess the quality of life in patients with ovarian cancer after treatment with anti- MESO CAR-T cells.
The goal of this clinical trial is to study the safety and feasibility of anti- Mesothelin Chimeric Antigen Receptor T-Cell (MESO CAR-T cells) therapy for Refractory-Relapsed Ovarian Cancer